Literature DB >> 19497867

mTOR complex 2 in adipose tissue negatively controls whole-body growth.

Nadine Cybulski1, Pazit Polak, Johan Auwerx, Markus A Rüegg, Michael N Hall.   

Abstract

Mammalian target of rapamycin (mTOR), a highly conserved protein kinase that controls cell growth and metabolism in response to nutrients and growth factors, is found in 2 structurally and functionally distinct multiprotein complexes termed mTOR complex 1 (mTORC1) and mTORC2. mTORC2, which consists of rictor, mSIN1, mLST8, and mTOR, is activated by insulin/IGF1 and phosphorylates Ser-473 in the hydrophobic motif of Akt/PKB. Though the role of mTOR in single cells is relatively well characterized, the role of mTOR signaling in specific tissues and how this may contribute to overall body growth is poorly understood. To examine the role of mTORC2 in an individual tissue, we generated adipose-specific rictor knockout mice (rictor(ad-/-)). Rictor(ad-/-) mice are increased in body size due to an increase in size of nonadipose organs, including heart, kidney, spleen, and bone. Furthermore, rictor(ad-/-) mice have a disproportionately enlarged pancreas and are hyperinsulinemic, but glucose tolerant, and display elevated levels of insulin-like growth factor 1 (IGF1) and IGF1 binding protein 3 (IGFBP3). These effects are observed in mice on either a high-fat or a normal diet, but are generally more pronounced in mice on a high-fat diet. Our findings suggest that adipose tissue, in particular mTORC2 in adipose tissue, plays an unexpectedly central role in controlling whole-body growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497867      PMCID: PMC2700987          DOI: 10.1073/pnas.0811321106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

Review 2.  Metabolic effects of IGF-I deficiency: lessons from mouse models.

Authors:  Shoshana Yakar; Hui Sun; Hong Zhao; Patricia Pennisi; Yuka Toyoshima; Jennifer Setser; Bethel Stannard; Louis Scavo; Derek Leroith
Journal:  Pediatr Endocrinol Rev       Date:  2005-09

3.  Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity.

Authors:  Qian Yang; Ken Inoki; Tsuneo Ikenoue; Kun-Liang Guan
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

4.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.

Authors:  David A Guertin; Deanna M Stevens; Carson C Thoreen; Aurora A Burds; Nada Y Kalaany; Jason Moffat; Michael Brown; Kevin J Fitzgerald; David M Sabatini
Journal:  Dev Cell       Date:  2006-12       Impact factor: 12.270

Review 5.  Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions.

Authors:  Cunming Duan; Qijin Xu
Journal:  Gen Comp Endocrinol       Date:  2005-02-05       Impact factor: 2.822

6.  SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

Authors:  Estela Jacinto; Valeria Facchinetti; Dou Liu; Nelyn Soto; Shiniu Wei; Sung Yun Jung; Qiaojia Huang; Jun Qin; Bing Su
Journal:  Cell       Date:  2006-09-07       Impact factor: 41.582

7.  Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability.

Authors:  Chiyo Shiota; Jeong-Taek Woo; Jill Lindner; Kathy D Shelton; Mark A Magnuson
Journal:  Dev Cell       Date:  2006-09-07       Impact factor: 12.270

8.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

9.  Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency.

Authors:  Lan Liao; Robert K Dearth; Suoling Zhou; Ora L Britton; Adrian V Lee; Jianming Xu
Journal:  Endocrinology       Date:  2006-05-18       Impact factor: 4.736

10.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Authors:  Estela Jacinto; Robbie Loewith; Anja Schmidt; Shuo Lin; Markus A Rüegg; Alan Hall; Michael N Hall
Journal:  Nat Cell Biol       Date:  2004-10-03       Impact factor: 28.824

View more
  90 in total

1.  Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.

Authors:  Minsheng Yuan; Elizabeth Pino; Lianfeng Wu; Michael Kacergis; Alexander A Soukas
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  Autocrine effect of vascular endothelial growth factor-A is essential for mitochondrial function in brown adipocytes.

Authors:  Kiana Mahdaviani; David Chess; Yuanyuan Wu; Orian Shirihai; Tamar R Aprahamian
Journal:  Metabolism       Date:  2015-09-25       Impact factor: 8.694

3.  mTORC2 in the center of cancer metabolic reprogramming.

Authors:  Kenta Masui; Webster K Cavenee; Paul S Mischel
Journal:  Trends Endocrinol Metab       Date:  2014-05-21       Impact factor: 12.015

4.  Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.

Authors:  N Deblon; L Bourgoin; C Veyrat-Durebex; M Peyrou; M Vinciguerra; A Caillon; C Maeder; M Fournier; X Montet; F Rohner-Jeanrenaud; M Foti
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.

Authors:  Deqiang Zhang; Xin Tong; Blake Arthurs; Anirvan Guha; Liangyou Rui; Avani Kamath; Ken Inoki; Lei Yin
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 6.  mTOR: a pharmacologic target for autophagy regulation.

Authors:  Young Chul Kim; Kun-Liang Guan
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

7.  Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism.

Authors:  Anil Kumar; John C Lawrence; Dae Young Jung; Hwi Jin Ko; Susanna R Keller; Jason K Kim; Mark A Magnuson; Thurl E Harris
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

8.  Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.

Authors:  Vanessa P Houde; Sophie Brûlé; William T Festuccia; Pierre-Gilles Blanchard; Kerstin Bellmann; Yves Deshaies; André Marette
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

9.  Targeting TOR dependence in cancer.

Authors:  Matthew R Janes; David A Fruman
Journal:  Oncotarget       Date:  2010-05

Review 10.  An emerging role of mTOR in lipid biosynthesis.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Curr Biol       Date:  2009-12-01       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.